▲ | notahacker 6 days ago | ||||||||||||||||
I don't think patients who want to be addressed as a women particularly wish to end up 6'4" tall with broad shoulders, but those are unintended side effects of unwanted puberty for a significant number of people currently requesting blockers. So being smaller is literally an intended effect of choosing blockers. And the relatively small proportion of natal male patients that cease treatment go through puberty, hence the primary effect is not irreversible. Being statistically slightly smaller in stature wouldn't typically be classed as a harmful side effect of any other course of treatment, particularly where the purpose of the treatment was to ensure those choosing to continue successfully avoid more drastic and completely irreversible changes in stature before making a decision on hormones which actually are extremely difficult to reverse. Since we're insisting that WPATH and the AAP's evidence base is a bit thin, I'm sure I'm going to be wowed by the list of citations you produce for puberty blockers causing significant harm in the form of "brittle bones that are much likely to break"... The Cass Review found that a children's clinic didn't conduct followup exercises with adults and didn't regard other followup studies involving adult cohorts as conclusive. I haven't disputed that, or that medicine is typically more cautious than other sciences. What I am disputing is that the Cass Report concluded that puberty blockers were dangerous and irreversible when prescribed to people with gender dysphoria. I mean, if she actually believed that had been established, she wouldn't be recommending trials, right... | |||||||||||||||||
▲ | Manuel_D 6 days ago | parent [-] | ||||||||||||||||
> I don't think patients who want to be addressed as a women particularly wish to end up 6'4" tall with broad shoulders, but those are unintended side effects of unwanted puberty for a significant number of people currently requesting blockers. For the third time your claim was that puberty blockers are reversible. This is false. If this hypothetical child decided to stop taking puberty blockers, the impact on height would not be reversed. He would not reach the same height if he took blockers and stopped than if he never took blockers at all. Puberty blockers are not reversible. And again, impacts on bone density and inability to achieve orgasm are most certainly not desired and these side effects go entirely unmentioned in your response. I don't know why you imply there's no research on these side effects: https://pmc.ncbi.nlm.nih.gov/articles/PMC9578106/#:~:text=Re.... > Results consistently indicate a negative impact of long-term puberty suppression on bone mineral density, especially at the lumbar spine, which is only partially restored after sex steroid administration. Trans girls are more vulnerable than trans boys for compromised bone health. https://pmc.ncbi.nlm.nih.gov/articles/PMC9886596/#:~:text=Pu.... > Puberty blockers, cross-sex hormones and genital surgery also pose risks to sexual function, particularly the physiological capacity for arousal and orgasm. It is important to be aware there is a dearth of research studying the impact of GAT on GD youth’s sexual function, but I provide a brief discussion of this important topic. Estrogen use in transwomen is associated with decreased sexual desire and erectile dysfunction and testosterone for transmen may lead to vaginal atrophy and dyspareunia | |||||||||||||||||
|